Communiqués Diaceutics PLC

Actions

DXRX

GB00BJQTGV64

Services d'assistance aux entreprises

Marché Fermé - London S.E. 17:35:25 23/09/2026			Varia. 5j.	Varia. 1 janv.
191,50 ^GBX	+2,96 %		+19,69 %	+49,61 %

22/09	RÉSULTATS : Origin Enterprises dépasse son objectif de bénéfice d’exploitation	AN
22/09	Diaceutics PLC publie ses résultats pour le semestre clos le 30 juin 2026	CI

Communiqués

10/09/21	Diaceutics : Announces Two Poster Presentations at AMP 2021 Annual Meeting & Expo	BU
08/09/21	Diaceutics : Two New Experts Join the Diaceutics Advisory Panel	BU
04/06/21	Diaceutics : to Release Breakthrough Data on COVID-19 Impact on Cancer at 2021 American Society of Clinical Oncology (ASCO) Meeting	BU
13/05/21	Diaceutics : and LGC SeraCare Partnership Expands Diagnostic Commercialization Solutions Enabled by Global DXRX Platform	BU
12/04/21	Diaceutics : Appoints Yvanka Gilliam as Vice President of Operations, Asia Pacific	BU
04/03/21	Diaceutics : Appoints Nikita Lynn to Vice President of Finance	BU
18/01/21	Diaceutics : Canadian Pathology Quality Assurance Leverages Diaceutics’ DXRX Platform to Advance NTRK IHC Proficiency Testing	BU
22/12/20	Diaceutics : Appoints Seasoned Business Leader Deborah Davis as Non-executive Chair	BU
30/11/20	Diaceutics : and Alva10 partnership to deliver value-based test reimbursement model for US payers, pharma and testing providers via DXRX platform	BU
28/10/20	Diaceutics : Launches World’s First Diagnostic Network for Precision Medicine to Solve Global Cancer Testing Issues	BU
05/10/20	Diaceutics : Research Predicts NSCLC US Testing Market to Reach $3.6bn by 2025, but Solution Still Needed to Improve Patient Outcomes	BU
28/09/20	Diaceutics : Partners With Global EQA Providers to Implement Best-in-class Testing Standards	BU
14/09/20	Diaceutics : Unveils Expert Advisory Panel Powering its Industry-Changing Diagnostic Network DXRX	BU
14/07/20	Diaceutics : Partners With Targos and HistoCyte Laboratories to Drive Global Diagnostic Testing Standardization	BU
28/05/20	Diaceutics : Collaborates With Industry Advisor Network to Publish Multiple Cancer Insights	BU
18/05/20	Diaceutics : announces world’s first Diagnostic Network for Precision Medicine following $28m investment	BU
29/04/20	Diaceutics : Cancer Testing and Diagnosis Suffers Sharp Downturn, finds Diaceutics	BU
06/03/20	Diaceutics : FDA to Approve More Precision Than Non-precision Drugs By 2021 – Diaceutics	BU
17/02/20	Diaceutics : Belfast investor presentation	PU
21/10/19	Diaceutics: Half of Eligible Cancer Patients Missing out on Potentially Life-saving Drugs	BU